Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3RSG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,174
Award facts
- Contract value 100% obligated
- $1,173.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,173.57 to AmerisourceBergen Drug Corp for HEPLISAV-B 20 MCG/0.5 ML syringes on December 17, 2025, with completion scheduled for December 18, 2025. HEPLISAV-B is a recombinant hepatitis B vaccine indicated for adult immunization. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
This delivery order is issued under AmerisourceBergen's $999.99 billion indefinite delivery vehicle with DLA Troop Support Medical (contract SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen is a major pharmaceutical distributor providing a broad portfolio of brand-name and generic medications, vaccines, and medical supplies to federal customers including the Defense Health Agency and U.S. Coast Guard. The company's status as a prime vendor reflects its demonstrated capability to fulfill federal medical procurement requirements at scale across multiple therapeutic domains and geographic regions.
Quick answers
Who was awarded contract SPE2DR26F3RSG?
SPE2DR26F3RSG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F3RSG worth?
The government has obligated $1,174 on SPE2DR26F3RSG.
Is contract SPE2DR26F3RSG an order under another contract?
Yes. SPE2DR26F3RSG is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3RSG competed?
The extent of competition for SPE2DR26F3RSG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award